By Business Wire, October 14, 2013, 08:27:00 AM EDT
Quintiles Wins Society for Clinical Research Sites' 2013 Eagle Award
Recognizes Leadership & Professionalism in Site Support
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
today announced that the company has been awarded the Society for
Clinical Research Sites' (SCRS) 2013 Clinical Research Organization
(CRO) Eagle Award. The award recognizes outstanding leadership,
professionalism, integrity, passion and dedication and is voted on by
the sites themselves.
"Quintiles recognizes the vital and important role our dedicated and
highly skilled investigators and their site teams play in conducting
clinical research aimed at developing new and better medicines," said
Lindy Jones, senior vice president, Integrated Site Services, Quintiles.
"We are thrilled to receive the Eagle Award which recognizes that we
understand and are dedicated to working closely with all of our
investigative sites. We are especially pleased because we were chosen by
the sites themselves."
"We are delighted to present the Eagle Award to Quintiles," said SCRS
President Christine Pierre. The award reflects the opinions of more than
1,000 investigative sites across the globe. Quintiles' integrity in
consistently demonstrating their keen interest in partnering with sites
landed them with this prestigious recognition."
In selecting this year's nominees, investigative sites registering for
the Site Solutions Summit were asked to nominate the sponsor and CRO
they believe best demonstrate partnership commitment. Criteria for
selection included availability of qualified staff to support the sites,
willingness to collaborate, protocol design and execution, financial
consideration, and partnering with sites for future work. Finalists were
those sponsors and CROs that ranked in the 75th percentile or greater of
nominations received. Once the finalists were identified, voting was
open to all sites globally.
Of the participating sites, 60% were from North America, 23% from
Europe, 7% from South America, 3% from Asia-Pacific, 3% from Sub Saharan
Africa, and 4% from "other." Those who participated in the survey were
mostly investigators (35%), site directors (31%), and study coordinators
Quintiles (NYSE:Q) is the world's largest provider of biopharmaceutical
development and commercial outsourcing services with a network of more
than 27,000 employees conducting business in approximately 100
countries. We have helped develop or commercialize all of the top-50
best-selling drugs on the market. Quintiles applies the breadth and
depth of our service offerings along with extensive therapeutic,
scientific and analytics expertise to help our customers navigate an
increasingly complex healthcare environment as they seek to improve
efficiency and effectiveness in the delivery of better healthcare
outcomes. To learn more about Quintiles, please visit www.quintiles.com.
SCRS is a trade organization representing global clinical research sites
representing sites in 22 countries. SCRS' mission is to unify and
amplify the voice of the global clinical research site community. SCRS
has become an active partner in industry-wide dialogues focused on
improving the clinical research enterprise among the many industry
initiatives. Sites, as well as companies that sponsor or support the
work conducted at the clinical research sites, will benefit from
membership. Visit www.myscrs.org.
to subscribe to Mobile Alerts for Quintiles.